论文部分内容阅读
长期以来,腋淋巴结转移状况被认为是估价乳癌病人预后的一个重要指标.近十多年来人们发现乳癌细胞雌激素受体水平也是较好的预后标记之一.但是它们都不能直接地反应乳癌细胞的恶性侵袭程度或对每个乳癌病人的治疗和预后做出较客观的估价,而乳癌细胞DNA倍体水平的测定则能较好地反应这一点.近年国外有关这方面的许多研究结果初步表明,乳癌细胞DNA倍体水平对乳癌病人的预后及治疗的估价更具有意义.
Axillary lymph node metastasis has long been considered as an important indicator to evaluate the prognosis of breast cancer patients. In the past decade, it has been found that breast cancer cell estrogen receptor levels are also one of the better prognostic markers, but none of them can directly reflect breast cancer. The degree of malignant invasion of cells or the objective assessment of the treatment and prognosis of each breast cancer patient, but the determination of breast cancer cell DNA ploidy level can better reflect this point. In recent years, many foreign research results in this area are preliminary It shows that the DNA ploidy level of breast cancer cells is more meaningful for the prognosis and treatment of breast cancer patients.